
Commentary|Podcasts|June 3, 2025
New Programs Aim to Improve Implementation of Cardiovascular Interventions
Ralph Riello, PharmD, BCPS, a board-certified clinical pharmacy specialist at the Yale University School of Medicine, discusses challenges in implementation for novel cardiovascular treatments and interventions.
Advertisement
Ralph Riello, PharmD, BCPS, a board-certified clinical pharmacy specialist at Yale University School of Medicine, discusses challenges in implementation for novel cardiovascular treatments and interventions. In his work, Riello has researched the use of proactive messaging to providers to better implement new treatments, finding success with this approach.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
2
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
3
From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
4
FDA Grants Orphan Drug Designation to Zavabresib for the Treatment of Myelofibrosis
5





















